← The SEC Ephemeris: the whole map
Zydus Worldwide DMCC sitagliptin
In the graph: all 2 documents (4 pages).
- Application
- NDA 211566
- Ticker
- Zydus Worldwide DMCC
- Product
- sitagliptin
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- March 3, 2023 · September 2, 2021
From FDA letters and SEC filings. Not investment or medical advice.